Literature DB >> 17335986

Anti-metastatic activity of heparin is probably associated with modulation of SDF-1-CXCR4 axis.

Marian Simka.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17335986     DOI: 10.1016/j.mehy.2007.01.008

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


× No keyword cloud information.
  4 in total

1.  Modulating the interaction of CXCR4 and CXCL12 by low-molecular-weight heparin inhibits hepatic metastasis of colon cancer.

Authors:  Lixin Ma; Haiquan Qiao; Changjun He; Qian Yang; Chun Hei Antonio Cheung; Jagat R Kanwar; Xueying Sun
Journal:  Invest New Drugs       Date:  2010-11-16       Impact factor: 3.850

2.  Significantly inhibitory effects of low molecular weight heparin (Fraxiparine) on the motility of lung cancer cells and its related mechanism.

Authors:  Guo-xing Zhong; Yi Gong; Chuan-jiang Yu; Shi-fei Wu; Qing-ping Ma; Yu Wang; Jiang Ren; Xue-chao Zhang; Wei-han Yang; Wen Zhu
Journal:  Tumour Biol       Date:  2015-01-27

3.  The effect of therapeutic anticoagulation on overall survival in men receiving first-line docetaxel chemotherapy for metastatic castration-resistant prostate cancer.

Authors:  Jong Chul Park; Caroline F Pratz; Anteneh Tesfaye; Robert A Brodsky; Emmanuel S Antonarakis
Journal:  Clin Genitourin Cancer       Date:  2014-06-11       Impact factor: 2.872

Review 4.  The anti-cancer properties of heparin and its derivatives: a review and prospect.

Authors:  Sai-Nan Ma; Zhi-Xiang Mao; Yang Wu; Ming-Xing Liang; Dan-Dan Wang; Xiu Chen; Ping-An Chang; Wei Zhang; Jin-Hai Tang
Journal:  Cell Adh Migr       Date:  2020-12       Impact factor: 3.405

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.